Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,245 | 65 | 98.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17.90 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $511.58 | 21 | $0 (2022) |
| Merz North America, Inc. | $109.15 | 4 | $0 (2019) |
| US WorldMeds, LLC | $105.26 | 9 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $99.08 | 5 | $0 (2020) |
| ABBVIE INC. | $75.29 | 4 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $56.78 | 5 | $0 (2018) |
| Merz Pharmaceuticals, LLC | $44.75 | 1 | $0 (2021) |
| GENZYME CORPORATION | $44.74 | 3 | $0 (2020) |
| Depomed, Inc. | $29.67 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $27.86 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.32 | 2 | ABBVIE INC. ($36.32) |
| 2023 | $37.27 | 2 | Medtronic, Inc. ($20.65) |
| 2022 | $66.46 | 3 | Allergan, Inc. ($44.11) |
| 2021 | $63.54 | 2 | Merz Pharmaceuticals, LLC ($44.75) |
| 2020 | $60.78 | 3 | Ipsen Biopharmaceuticals, Inc ($21.33) |
| 2019 | $244.12 | 13 | Allergan Inc. ($98.67) |
| 2018 | $171.94 | 11 | Allergan Inc. ($57.26) |
| 2017 | $582.73 | 30 | Allergan Inc. ($274.08) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Drug Infusion Systems | ||||||
| 05/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/26/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/16/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/13/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: SPASTICITY | ||||||
| 09/22/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $44.75 | General |
| Category: Musculoskeletal | ||||||
| 02/27/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: SPASTICITY | ||||||
| 02/20/2020 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $20.78 | General |
| 02/05/2020 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Neurology | ||||||
| 12/04/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2019 | Medtronic USA, Inc. | SYNCHROMED (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Drug Infusion Systems | ||||||
| 10/10/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Sleep | ||||||
| 08/13/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $28.26 | General |
| Category: MUSCULOSKELETAL | ||||||
| 08/08/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/08/2019 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: XLH | ||||||
| 04/11/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $12.56 | General |
| Category: Musculoskeletal | ||||||
| 03/13/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/19/2019 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Neurology | ||||||
| 01/24/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/15/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: MUSCULOSKELETAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 501 | 34,185 | $927,668 | $243,398 |
| 2022 | 19 | 569 | 25,323 | $763,686 | $194,539 |
| 2021 | 18 | 507 | 25,416 | $746,904 | $192,999 |
| 2020 | 18 | 470 | 24,802 | $715,163 | $176,511 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2021 | 19 | 61 | $5,795 | $1,467 | 25.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $3,585 | $1,336 | 37.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 30 | $3,480 | $1,287 | 37.0% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Office | 2021 | 11 | 31 | $6,335 | $960.71 | 15.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 12 | 25 | $500.00 | $146.73 | 29.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 31 | 24,000 | $408,000 | $113,882 | 27.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 47 | 104 | $24,128 | $7,802 | 32.3% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2020 | 20 | 50 | $68,530 | $6,827 | 10.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 49 | 49 | $17,885 | $6,230 | 34.8% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles | Office | 2020 | 27 | 78 | $28,158 | $5,617 | 19.9% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Office | 2020 | 32 | 80 | $17,040 | $4,773 | 28.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 39 | 60 | $16,320 | $4,604 | 28.2% |
| 64642 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles | Office | 2020 | 22 | 61 | $37,942 | $4,354 | 11.5% |
| 64644 | Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles | Office | 2020 | 13 | 33 | $16,401 | $4,012 | 24.5% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 19 | 20 | $14,700 | $3,446 | 23.4% |
| 64646 | Injection of chemical for destruction of nerve muscles on trunk, 5 or more muscles | Office | 2020 | 18 | 46 | $23,138 | $3,257 | 14.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 49 | $8,330 | $2,872 | 34.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 38 | 40 | $8,840 | $2,319 | 26.2% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2020 | 20 | 20 | $9,060 | $2,124 | 23.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 13 | $5,460 | $1,446 | 26.5% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2020 | 20 | 48 | $4,560 | $1,183 | 25.9% |
| 98926 | Osteopathic manipulative treatment to 3-4 body regions | Office | 2020 | 14 | 29 | $4,031 | $1,061 | 26.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 20 | 22 | $2,640 | $700.78 | 26.5% |
About Dr. Li-Hong Lu, M.D
Dr. Li-Hong Lu, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497713861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Li-Hong Lu, M.D has received a total of $1,263 in payments from pharmaceutical and medical device companies, with $36.32 received in 2024. These payments were reported across 66 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,245).
As a Medicare-enrolled provider, Lu has provided services to 2,047 Medicare beneficiaries, totaling 109,726 services with total Medicare billing of $807,447. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Wyomissing, PA
- Active Since 05/03/2006
- Last Updated 05/15/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1497713861
Products in Payments
- BOTOX (Biological) $231.15
- BOTOX NEURO REHAB (Drug) $193.72
- Xeomin (Biological) $106.50
- BOTOX (Drug) $81.08
- APOKYN (Drug) $57.21
- NUPLAZID (Drug) $56.78
- XEOMIN (Biological) $47.40
- DYSPORT (Drug) $40.32
- Dysport 300 U-1 (Drug) $37.05
- BOTOX THERAPEUTIC (Biological) $32.40
- Nucynta (Drug) $29.67
- MYOBLOC (Biological) $28.90
- ELIQUIS (Drug) $27.86
- LUMIZYME (Drug) $23.96
- Dysport (Drug) $21.71
- SYNCHROMEDII (Device) $20.65
- BOTOX - SPASTICITY (Drug) $20.13
- Xadago (Drug) $19.15
- SYNCHROMED (Device) $18.55
- BOTOX - NEUROLOGY (Drug) $18.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Wyomissing
Haiping Mei, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,696
Kelley Crozier, Md, MD
Physical Medicine & Rehabilitation — Payments: $730.41
Sanghoon Kim, Md, MD
Physical Medicine & Rehabilitation — Payments: $588.08
Paul Brockman, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $435.07
Somkiat Hemtasilpa, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $428.76
Mary Elmer
Physical Medicine & Rehabilitation — Payments: $215.26